ODOB > Events > 50723 Drug Considerations in the Medical Management of Adult Open Angle Glaucoma

50723 Drug Considerations in the Medical Management of Adult Open Angle Glaucoma

Date: Tue 29/03/2022 - Fri 29/03/2024

Provider: Mivision

Optometrist Credits: 0.75 general credits

Event Type(s): Online

Contact


Topical intraocular lowering therapies are associated with varied ocular and systemic adverse effects; they can cause drug interactions and impact on co-morbidities.

 

Unaddressed adverse events can compromise adherence, treatment outcomes and potentially, patients’ health. Selecting effective and well tolerated drugs is an important

consideration in the management of glaucoma. Recognising susceptibility to adverse

events, early identification and appropriate intervention, markedly improves outcomes.

This article discusses a few important common and less common adverse effects associated with frequently used classes of anti-glaucoma drugs, as well as strategies to minimise or prevent adverse events.

Log this activity to my CPD

Location

This event does not have a physical location